Younes Houssam K, Davies Mark G, Peden Eric K
Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas, USA.
Methodist Debakey Cardiovasc J. 2013 Apr;9(2):108-11. doi: 10.14797/mdcj-9-2-108.
The prevalence of peripheral arterial disease and both traditional and nontraditional vascular risk factors are more common in patients with end-stage renal disease who are undergoing hemodialysis than the general population. Patients undergoing hemodialysis may also be at risk for peripheral arterial disease via nonvascular risk factors and the hemodialysis treatment itself. Unfortunately, because peripheral arterial disease and its risk factors in hemodialysis patients have not been thoroughly ascertained, evaluation of potential treatments has been limited. Given the high potential of morbidity and impaired quality-of-life related to peripheral arterial disease in patients with end-stage renal disease, additional studies are needed to evaluate both quality of life and potential screening for peripheral arterial disease, its risk factors, and treatments to identify areas for improvement in this vulnerable population.
与普通人群相比，正在接受血液透析的终末期肾病患者外周动脉疾病以及传统和非传统血管危险因素的患病率更高。接受血液透析的患者也可能通过非血管危险因素和血液透析治疗本身而面临外周动脉疾病的风险。不幸的是，由于尚未彻底确定血液透析患者的外周动脉疾病及其危险因素，对潜在治疗方法的评估一直很有限。鉴于终末期肾病患者外周动脉疾病导致的高发病可能性和生活质量受损，需要开展更多研究来评估生活质量以及对外周动脉疾病、其危险因素和治疗方法进行潜在筛查，以确定这一弱势群体中有待改善的领域。
